KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy-Reference-Cited by-同舟云学术

KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy

Published:2010-01 Issue:1 Volume:94 Page:76-81
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Gaedcke Jochen,Grade Marian,Jung Klaus,Schirmer Markus,Jo Peter,Obermeyer Christoph,Wolff Hendrik A.,Herrmann Markus K.,Beissbarth Tim,Becker Heinz,Ried Thomas,Ghadimi Michael

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference36 articles.

1. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors;Hoshino;Oncogene,1999

2. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair;Wang;Cancer Res,2003

3. Ras oncogenes: split personalities;Karnoub;Nat Rev Mol Cell Biol,2008

4. K-ras mutations and benefit from cetuximab in advanced colorectal cancer;Karapetis;N Engl J Med,2008

5. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N Engl J Med,2009

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatic pharmacogenomics in the treatment prognosis of locally advanced rectal cancer patients: a narrative review of the literature;Expert Review of Clinical Pharmacology;2024-07-24

2. Five decades of colorectal cancer pathology: The World and China;Chinese Science Bulletin;2024-05-01

3. The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1^st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wtRAS) – a real- life data report 2013–2018;Radiology and Oncology;2023-03-01

4. Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis;Cancers;2023-02-25

5. Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer;Frontiers in Oncology;2022-07-04